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Background and purpose   Little is known about the effect of 
the learning curve for different types of total hip arthroplasties 
(THAs). We investigated the prostheses survival of THAs just 
after the implementation of a model new to the hospital, and com-
pared these results with the results of THAs done when more than 
100 implantations had been undertaken. In addition, we investi-
gated whether differences exist between different types of femoral 
stems and acetabular cups at the early implementation phase.
Patients and methods   We used comprehensive registry 
data from all units (n = 76) that performed THAs for primary 
osteoarthritis in Finland between 1998 and 2007. Complete data 
including follow-up data to December 31, 2010 or until death were 
available for 33,819 patients (39,125 THAs). The stems and cups 
used were given order numbers in each hospital and classified into 
5 groups: operations with order number (a) 1–15, (b) 16–30, (c) 
31–50, (d) 51–100, and (e) > 100. We used Cox’s proportional haz-
ards modeling for calculation of the adjusted hazard ratios for the 
risk of revision during the 3 years following the implementation of 
a new THA endoprosthesis type in the groups.
Results   Introduction of new endoprosthesis types was common, 
as more than 1 in 7 patients received a type that had been pre-
viously used in 15 or less operations. For the first 15 operations 
after a stem or cup type was introduced, there was an elevated 
risk of revision (hazard ratio (HR) = 1.3, 95% CI: 1.1–1.5). There 
were differences in the risk of early revision between stem and 
cup types at implementation.
Interpretation   The first 15 operations with a new stem or cup 
model had an increased risk of early revision surgery. Stems and 
cups differed in their early revision risk, particularly at the imple-
mentation phase. Thus, the risk of early revision at the implemen-
tation phase should be considered when a new type of THA is 
brought into use.

Based on comparisons of implant survival, the type of THA 
model has an effect on the long-term risk of revision surgery 
(Mäkelä et al. 2008, 2010). However, very little is known 
about the effect of the introduction of a new THA model 
on the risk of early revision. Recently, Anand et al. (2011) 
showed that more than a quarter of the new endoprosthesis 
types introduced into the Australian market had a higher revi-
sion rate than established models, with a minimum duration of 
follow-up of 5 years.
Higher risk of early revision has already been shown with 
total knee arthroplasty (TKA) when introducing a new type 
of endoprosthesis in a hospital (Peltola et al. 2012). This phe-
nomenon is to be expected when, in TKA, optimal implant 
positioning strongly depends on precise and familiar use of 
implant-specific instrumentation (such as resection guides and 
cutting blocks). In THA, however, such factors may play a less 
important role. We therefore hypothesized that the first THA 
patients to be operated on with any endoprosthesis would not 
have a higher revision rate than patients whose implants were 
well known. 
In addition to studying the overall effect of implementation 
of new models, we analyzed specific differences in femoral 
stem and acetabular cup types regarding early revision risk 
during the implementation phase by studying the 10 most 
common stem and cup pairs.
Patients and methods
We identified all 36,626 patients in the Finnish Arthroplasty 
Register (FAR) who had had primary THA (42,673 opera-
tions) due to OA between January 1, 1998 and December 
31, 2007. Of these, we excluded 2,107 operations (in 1,607 
patients) for which information regarding the endoprosthesis 
type (the name of either the stem or cup component) or the 
fixation technique was missing. Also, operations with resur-
facing arthroplasty were excluded (n = 1,441). After exclu-
sions, the final study data included 33,819 patients who had 
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had died before the end of follow-up (Table 1). The data are 
hip-specific. Altogether, 2,346 revisions were done on these 
before December 31, 2010, and 1,269 of the revisions were 
done within 3 years of the primary operation.
We linked data in the FAR for the period 1998–2010 with 
data in hospital discharge registers for the period 1998–2010 
using personal identification numbers. The coverage and 
reliability of the registers is high (Keskimäki and Aro 1991, 
Puolakka et al. 2001, Gissler and Haukka 2004). The FAR 
contains information from primary and revision THAs per-
formed in Finland since 1980, from every clinic performing 
arthroplasty. We also linked the death statistics from Statistics 
Finland to the data to take account of the censoring of patients. 
We used both the discharge register and the arthroplasty reg-
ister to track all the revisions performed. Revisions are reli-
ably recorded in registers, and they are an accepted outcome 
measure in register-based THA research (Serra-Sutton et al. 
2009). For analysis of the effect of endoprosthesis introduc-
tion on early revision, the follow-up was restricted to 3 years 
since revisions soon after the primary operation are often due 
to technical shortcomings in the primary operation, while 
later revisions are more likely to be the result of normal wear 
(Clohisy et al. 2004, Dobzyniak et al. 2006, Mäkelä et al. 
2008, 2010). In this study, revisions for any reason—includ-
ing removal of an endoprosthesis—were considered to be true 
revisions.
From the FAR, we obtained the number of every 
endoprosthesis type used between January 1, 1980 and Decem-
ber 31, 1997. This was done separately for each hospital, and 
for different types of stem and cup components. Using hip-
specific data from the FAR from January 1, 1998 to Decem-
ber 31, 2007, for each THA carried out during this period we 
defined the ordinal number of the stem and cup component in 
the operating hospital. 
A stem is not necessarily used together with a specific cup, 
and there are numerous stem and cup combinations (pairs), 
which complicates the analyses. We formed 2 versions of pair-
wise order numbering based on the lower (minimum) and the 
higher (maximum) order number of the stem or cup in a pair. 
Thus, for analysis of an overall learning effect in THA when 
introducing a new model not used previously in the hospital, 
we constructed 3 statistical models: 2 models with pairwise 
order numbering, and 1 model including both the stem and 
cup order numberings individually. 
We classified the operations with respect to the ordinal 
number into 5 classes: group A (operations with order number 
1–15), group B (16–30), group C (31–50), group D (51–100), 
and group E (over 100). We compared the cases in groups A 
to D with those in group E. We used Cox’s proportional haz-
ards model to compare the groups so that censoring because 
of deaths and the timing of the revision would be taken into 
account. Because we knew the dates of both primary surgery 
and revision surgery, we used the time in days from primary 
surgery to revision or censoring as the dependent variable. 
We performed the analysis in 2 stages. First, we estimated 
the different types in the whole study to investigate the overall 
effect of implementation of new implant types. We performed 
4 estimations with an incrementally wider set of confounding 
variables, and used the Akaike and Bayesian information cri-
teria (AIC and BIC, respectively) to evaluate the performance 
of the model. With this approach, we wanted to perform exten-
sive adjustments for potentially confounding factors, at the 
same time checking that we were not overadjusting. The first 
model was unadjusted, the second model was adjusted with 
patient characteristics (sex, and age classified into 5 groups 
(< 51, 51–60, 61–70, 71–80, and > 80 years)), the third model 
had operation-related variables added, and the fourth model 
had hospital-level variables added. We included cementing, 
bilaterality (both hips in the same operation), bone graft use, 
and intravenous antibiotic prophylaxis as operation-related 
variables. The hospital-level variables possibly affecting the 
outcome of primary surgery were constructed for each calen-
dar year (share of hospital arthroplasty volume taken by THA, 
hospital’s femoral model use per 100 THAs, and hospital 
hip arthroplasty volume). Model 2 was stratified for sex, and 
models 3 and 4 were stratified for sex and fixation technique. 
Based on the information criteria, model 2 with age and sex 
only was better than the more complex models 3 and 4. In 
Table 1. Descriptive statistics for 39,125 total hip arthroplasty oper-
ations in Finland from 1998 to 2007
  N %
Total no. of operations 39,125 100
Sex  
 Male 16,849 43.1
Age  
 < 50 years 1,044 2.7
 50–59 years 5,929 15.2
 60–69 years  12,991 33.2
 70–79 years 15,258 39.0
 ≥ 80 years 3,903 10.0
Operation  
 Bilateral 1,373 3.5
 Cemented 18,072 46.2
 Cementless 14,769 37.7
 Hybrid 6,284 16.1
 Bone grafts 1,468 3.8
 Intravenous prophylactic antibiotics 38,535 98.5
Operations with the 10 most common 
 stem and cup pairs 22,271 56.9
The 10 most common stem and cup pairs  
   1 Exeter Universal / Contemporary 5,925 15.1
   2 Spectron EF / Reflection All-Poly 2,868 7.3
      3 Exeter Universal / Exeter All-Poly 2,838 7.3
   4 Biomet Collarless / Biomet Vision 2,210 5.6
   5 Link Lubinus SP II / Link IP Acetabular Cups 1,712 4.4
   6 ABG II / ABG II 1,617 4.1
   7 ABG HA / ABG II 1,436 3.7
   8 Link Lubinus SP II / Link Lubinus Eccentric 1,430 3.7
   9 Biomet Collarless / Recap (Biomet) 1,284 3.3
 10 Biomet Collarless / M2A 38 Flared
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addition to the age- and sex-adjusted results, we also present 
the unadjusted hazard ratios for the ordinal number classes.
In the second phase, we identified the 10 most common stem 
and cup pairs and separated Cox model analyses for the pairs 
with at least 100 observations in the different ordinal number 
groups. For each selected pair, the model was estimated for the 
cases with this pair only with the operations in group E (over 
100 operations with the pair in the hospital) as the reference, 
using the order numbering of the stem and cup separately, or 
the pairwise order numbering (both minimum and maximum). 
For the pairs, we present only age- and sex-adjusted hazard 
ratios. 
In all models, the proportional hazards assumption was 
investigated by testing for a non-zero slope in a generalized 
linear regression of the scaled Schoenfeld residuals on func-
tions of time (Grambsch and Therneau 1994). In our data, a 
person may have 2 observations. We tested and found that the 
violation of the assumption of independent observations did 
not affect the results. In addition, we considered the clustering 
of patients in hospitals by performing all the analyses with 
shared gamma frailty models. The results of these models were 
almost identical to the results of conventional Cox regression 
models that we present.
The study was approved by the ethics committee of the 
National Institute for Health and Welfare in Finland on Janu-
ary 28, 2010.
Results
Descriptive statistics of the entire study population are given 
in separate tables for operation-specific and hospital-specific 
variables (Tables 1 and 2, respectively). In the data, there are 
96 stem types and 85 cup types. These components were used 
in 467 different combinations, i.e. different stem and cup pairs. 
A large proportion of the endoprosthesis models had been 
used in only a small number of operations. Of the stem types, 
62 were used in less than 100 operations; of the cup types, 47 
were used in less than 100 operations, accounting for about 
3% of the operations. During the study period, altogether 87 
stem and 79 cup brands were introduced in at least 1 hospital. 
These introductions contributed to 5,967 operations in the first 
stage of introduction of a new endoprosthesis model (opera-
tions in group A with pairwise minimum order numbering) in 
all of the 76 hospitals in the period from January 1, 1998 to 
December 31, 2007. Of all the operations, almost 1 in 6 were 
done in the first stage of introducing the endoprosthesis (group 
A, pairwise minimum order numbering). Cups accounted for a 
larger share of these introductions than stems. 
The unadjusted hazard ratios show that the first 15 operations 
with a new endoprosthesis model had a higher risk of early 
revision for the order numbering of both stem and cup brands, 
and also for the combined order numbering. The risk of early 
revision was statistically significant also in the age- and sex-
adjusted model (HR = 1.3, 95% CI: 1.1–1.5) (Table 3). Thus, 
in THA performed due to osteoarthritis, there appears to have 
been a learning curve due to the introduction of a new stem or 
cup type. The smoothed hazard function showed that the risk 
of revision rapidly declined during the first 3 years after the 
primary operation (Figure). Most of the early revisions were 
performed during the year after the primary operation. 
We also performed separate analyses of the 10 most common 
stem and cup pairs in order to analyze the pair-specific learn-
ing effect (Table 4). Specifically, we analyzed the stem- and 
cup-specific differences in early revision risk for the order 
number groups when compared to the operations with the 
same implant pair having an order number greater than 100.
The model-specific analyses (Table 5) showed that 3 out of 
10 pairs had an increased risk of early revision at the intro-
duction phase. Early revision risk after the implementation of 
a new endoprosthesis type increased with the Contemporary 
cup (operations 1 to 15: HR = 2.6, CI: 1.6–4.2) in the Exeter 
Universal/Contemporary pair, the Spectron EF stem (HR = 
2.1, CI: 1.0–4.1) in the Spectron EF/Reflection All-Poly pair, 
and with the ABG HA stem (HR = 2.7, CI: 1.1–6.5) in the 
ABG HA/ABG II pair. 
Discussion
We found a learning curve in THA when a new stem or cup 
type was introduced. For the first 15 operations, the risk was 
elevated (HR = 1.3, CI: 1.1–1.5). However, there were dif-
ferences in the type-specific early revision risk between the 
stages of introduction, reflecting that some types are easier 
to implement than others. We also found that the introduction 
of new endoprosthesis types is common in Finland, with 1 in 
every 7 patients receiving an endoprosthesis type during its 
implementation phase at that hospital (with 15 or less previous 
operations). 
The possibility of identifying the stage of introduction of 
an endoprosthesis type for each individual patient in a nation-
Table 2. Descriptions of the hospital-level variables in a study of 
endoprosthesis implementation in Finland for 39,125 THA opera-
tions
Proportion of arthroplasty operations in 
   hospital that were THAs, mean (SD) 0.58 (0.10)
Proportion of all operations in hospital 
   that were arthroplasty, mean (SD) 0.13 (0.21)
Femur models per 100 THAs in 
   hospital, mean (SD) 5.51 (4.74)
Hospital’s annual arthroplasty volume, n (%)
< 51 operations 2,135 (5.5)
51–150 operations 9,999 25.6)
151–300 operations 8,814 (22.5)
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wide population provides unique data. Patients’ personal 
identification numbers enable linking of hospital discharge 
register data with implant register data individually for opera-
tion details and outcomes. The present study covers an entire 
population of patients with OA who underwent THA over a 
13-year period, and the findings reflect ordinary healthcare 
practice. Furthermore, the analysis was performed on a large 
not enough to warrant a revision. In our material, we do not 
have reliable information on the reasons for the revision. In 
addition, some patient characteristics such as body mass index 
and physical activity were not available in the register.
Hospital arthroplasty volume, surgical expertise, and a sur-
geon’s annual case load may reduce the revision risk, although 
the current evidence is inconclusive (Losina et al. 2004, Judge 
et al. 2006, Shervin et al. 2007, Manley et al. 2008). We formed 
statistical models where we controlled for hospital arthroplasty 
volumes in the analysis of the overall effect of implementa-
tion on risk of early revision. The Cox proportional hazards 
regression for the whole study population showed that, after 
adjusting for all the patient-, operation-, and hospital-specific 
variables, the estimated hazard ratios for the stages of intro-
duction were not statistically significantly different. However, 
statistical testing suggested that this model performed worse 
than the simpler age- and sex-adjusted model, and due to the 
risk of over-adjusting we discarded this model. 
The register data do not indicate who operated on each 
patient. Surgeons differ in their skill and case load, and this 
could have an effect on revision risk. For instance, in the case 
of an experienced surgeon moving to another hospital, he or 
she might start in the new hospital with prostheses that are 
familiar and yet new to the hospital. This could lead to an 
apparent decrease in the revision risk for introductions. 
Table 3. Estimated hazard ratios for revision over 3 years after primary THA in a popula-
tion-based study of 39,125 operations
     Age- and
Ordinal number group  No. of No. of Unadjusted sex-adjusted
   Operation operations revisions HR (95% CI) HR (95% CI) 
 
                   
Minimum of stem and cup order numbers
 1–15 5,967 228 1.3 (1.1–1.6)  1.3 (1.1–1.5)
 16–30 3,980 123 1.1 (0.9–1.3)  1.1 (0.9–1.3)
 31–50 4,185 135 1.1 (0.9–1.3)  1.1 (0.9–1.3)
 51–100 6,820 220 1.1 (1.0–1.3)  1.1 (1.0–1.3)
 101– 18,173 527 1.0    1.0  
Maximum of stem and cup order numbers
 1–15 2,428 89 1.2 (1.0–1.5)  1.2 (1.0–1.5)
 16–30 1,868 59 1.1 (0.8–1.4)  1.0 (0.8–1.4)
 31–50 2,264 86 1.3 (1.0–1.6)  1.2 (1.0–1.5)
 51–100 4,226 153 1.2 (1.0–1.4)  1.2 (1.0–1.4)
 101– 28,339 846 1.0    1.0  
Stem and cup order number separately in the same model
Stem            
 1–15 3,653 141 1.3 (1.1–1.5)  1.1 (0.9–1.4)
 16–30 2,536 76 1.0 (0.8–1.3)  0.9 (0.7–1.2)
 31–50 2,740 93 1.1 (0.9–1.4)  1.0 (0.8–1.3)
 51–100 4,707 162 1.1 (1.0–1.3)  1.1 (0.9–1.3)
 101– 25,489 761 1.0    1.0  
Cup             
  1–15 4,742 176 1.3 (1.1–1.5)  1.2 (1.0–1.4)
 16–30 3,312 106 1.1 (0.9–1.4)  1.1 (0.9–1.4)
 31–50 3,709 128 1.2 (1.0–1.4)  1.1 (0.9–1.4)
 51–100 6,339 211 1.2 (1.0–1.4)  1.1 (1.0–1.3)
 101– 21,023 612 1.0    1.0
  
The smoothed hazard function for revision after primary THA during 
the follow-up in a population-based study of 39,125 THAs.
number of operations with a great vari-
ety of endoprosthesis types. The register-
based approach allows accurate follow-up 
of the patients with a minimum number 
of dropouts. We believe that the external 
validity of our findings is high.
Some limitations of the study should be 
considered. Since there was usually more 
than 1 endoprosthesis type in use in each 
hospital, we could not quantify the true 
amount of technical change linked to the 
introduction of a particular endoprosthesis. 
That is, a new implant could be substan-
tially similar to a previously used model 
and might not reflect an essential change 
in technology or surgical technique. From 
our data, we may therefore have underes-
timated the risk of early revision regarding 
major changes in surgical technique. 
The most common causes of THA revi-
sion surgery are aseptic loosening, insta-
bility, wear, and infection (Clohisy et al. 
2004, Mäkelä et al. 2008, 2010, Jafari et 
al. 2010). The degree of pain relief and dis-
ability varies after THA, and our data may 
have underestimated the harmful effects of 
introducing an endoprosthesis model, i.e. 
there may have been patients with residual 
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The learning curve of an orthopedic surgeon has been dis-
cussed in the literature, and some studies have been done on 
the effect of the learning curve on a certain operative tech-
nique or implementation of new technology, such as mini-
mally invasive surgery or hip resurfacing (Archibeck and 
White 2004, Laffosse et al. 2006, Cobb et al. 2007, Seyler et 
al. 2008, Jablonski et al. 2009, Seng et al. 2009, Nunley et al. 
2010, Berend et al. 2011). Most studies have been based on a 
consecutive series of patients in a single hospital, usually with 
a single surgeon, and the learning effect is often evaluated 
with measures related to the operation only (e.g. operating 
room time, blood loss). We are not aware of any studies that 
have analyzed at a population level the overall effect of hip 
endoprosthesis introduction on the early revision rate. Also, 
we are not aware of any studies that have tried to quantify the 
effect of endoprosthesis introduction in a hospital specifically 
for a named endoprosthesis model.
We found an increased risk of early revision at the intro-
duction of some endoprosthesis models (Table 5). All these 
models have proven to have reasonable long-term results 
(Mäkelä et al. 2008, 2010). In our register data, the reason for 
revision cannot be reliably identified and, thus, an explanation 
for increased risk of early revision in the introduction of a dis-
tinct type cannot be given. However, the variation in revision 
risk associated with the introduction of a new endoprosthesis 
type in hospital emphasizes the importance of type selection, 
careful practice with new instruments before the first opera-
tion, and the importance of implant and instrument design.
Both internal and external factors have an effect on the choice 
of endoprostheses in a hospital. Internal, hospital-specific, or 
surgeon-specific factors include the degree of frustration with 
the THA model in use (from poor results, complications, or 
technical troubles), the desire of a newly recruited surgeon to 
start using an endoprosthesis model that is familiar from his/her 
old workplace but perhaps new in the current hospital, and the 
expectation that better results could be obtained with another 
model following the accumulation of scientific evidence (long-
term results). External factors include new technical innova-
tions and the expectation of better results from endoprosthesis 
types following a new innovation, active marketing, the cost of 
components, and the regulation of public procurement. Also, 
suggestions from authorities and colleagues at meetings and 
at educational events may have an impact on the choice of 
endoprostheses at a particular hospital. The learning effect of 
endoprosthesis implementation should always be taken into 
account when a new endoprosthesis model is introduced into 
a hospital. In particular, hospital management should have the 
learning effect of an endoprosthesis in mind when considering 
any changes in implant selection that are based on competitive 
tendering or purely on costs.
Table 4. Number of operations in stages of introduction for the 10 most common stem and cup pairs
Numbering based on Pair
   Operation order number 1 2 3 4 5 6 7 8 9 10
           
 No. of operations 5,925 2,868 2,838 2,210 1,712 1,617 1,436 1,430 1,284 951
 No. of early revisions 153 60 90 81 59 60 38 37 38 26
 No. of hospitals 53 34 31 45 18 33 34 25 35 24
Combined (minimum)
 1–15    404 a    347 a    125    367 a      38    299 a    172 a      50    200 a   249 a
 16–30    387 a    277 a      48    266 a      27    228 a    165 a      34    181 a   167 a
 31–50    478 a    286 a    101    335 a      35    220 a    224 a      92    198 a   160 a
 51–100    865 a    471 a    324    443 a      89    410 a    428 a    262    271 a   258 a  
 101– 3,791 a 1,487 a 2,240    799 a 1,523    460 a    447 a    992    434 a   117 a
Combined (maximum)
 1–15    227 a    320 a      86      54      33      82    117 a      29      17   144
 16–30    227 a    255 a      57      38      29      50    122 a      16      38     59
 31–50    314 a    266 a      85      85      35      61    126 a      28      51     68
 51–100    624 a    463 a    250    145      87    198    360 a      13      77   102
 101– 4,533 a 1,564 a 2,360 1,888 1,528 1,226    711 a 1,344 1,101   316
Stem
 1–15    233 a    323 a      87      65      34    298 a    151 a      29      17     25
 16–30    231 a    259 a      56      46      29    228 a    117 a      16      38     23
 31–50    311 a    276 a      85      99      35    214 a    135 a      28      51     26
 51–100    634 a    472 a    251    159      89    412 a    353 a      37      81     59
 101– 4,516 a 1,538 a 2,359 1,841 1,525    465 a    680 a 1,320 1,097   818
Cup
 1–15    398 a    344 a    124    356 a      37      83    138 a      50    200 a   249 a
 16–30    383 a    273 a      49    258 a      27      50    170 a      34    181 a   167 a  
 31–50    481 a    276 a    101    321 a      35      67    215 a      92    198 a   160 a
 51–100    855 a    462 a    323    429 a      87    196    435 a    238    267 a   258 a
 101– 3,808 a 1,513 a 2,241    846 a 1,526 1,221    478 a 1,016    438 a   117 a
                       
a
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Our results show that the first 15 operations with a new stem 
or cup model have an increased risk of early revision surgery. 
In addition, our analysis indicates that there are differences 
in the risk of early revision between stem and cup models not 
previously used in a hospital. At this time, there are numer-
ous endoprosthesis models and brands available on the market 
and new models are likely to emerge because of the demand 
for and marketing of new technology. Although introduction 
of potentially better endoprosthesis models is important, there 
is a need for managed uptake of new technology. Our results 
further support the IDEAL recommendations for evaluation 
of new surgical interventions (McCulloch et al. 2009). Sur-
geons should be aware of the risks and should preferably prac-
tice with the new type beforehand. Surgical units performing 
arthroplasties might consider the challenge of introducing 
Jablonski M, Gorzelak M, Turzanska K, Pojasek S, Majchrzak D, Pluta R. 
Modified swanson’s hip replacement--intraoperative complications and 
learning curve of the procedure. Chir Narzadow Ruchu Ortop Pol 2009; 
74 (1): 5-8.
Jafari S M, Coyle C, Mortazavi S M, Sharkey P F, Parvizi J. Revision hip 
arthroplasty: Infection is the most common cause of failure. Clin Orthop 
2010; (468) (8): 2046-51.
Judge A, Chard J, Learmonth I, Dieppe P. The effects of surgical volumes 
and training centre status on outcomes following total joint replacement: 
Analysis of the hospital episode statistics for england. J Public Health 
2006; 28 (2): 116-24.
Keskimäki I, Aro S. Accuracy of data on diagnoses, procedures and accidents 
in the finnish hospital discharge register. Int J Health Sci 1991; 2: 15-21.
Laffosse J M, Chiron P, Accadbled F, Molinier F, Tricoire J L, Puget J. Learn-
ing curve for a modified watson-jones minimally invasive approach in pri-
mary total hip replacement: Analysis of complications and early results 
versus the standard-incision posterior approach. Acta Orthop Belg 2006; 
72 (6): 693-701.
Table 5. Pair-specific age- and sex-adjusted hazard ratios for stages of implant introduction a
A B C D E F
       
1 1–15 2.5  (1.5–4.1) 1.2  (0.5–2.7) 1.1  (0.5–2.6) 2.6  (1.6–4.2)
 16–30 2.2  (1.3–3.7) 1.7  (0.9–3.3) 1.7  (0.8–3.3) 2.3  (1.4–3.8)
 31–50 1.7  (1.0–2.8) 2.1  (1.2–3.5) 2.2  (1.3–3.7) 1.5  (0.9–2.7)
  51–100 1.5  (0.9–2.3) 1.4  (0.9–2.3) 1.3  (0.8–2.2) 1.5  (1.0–2.4)
 100– 1.0 1.0 1.0 1.0 
2 1–15 1.9  (0.9–3.7) 2.1  (1.1–4.2) 2.1  (1.0–4.1) 1.9  (1.0–3.8)
 16–30 1.0  (0.4–2.7) 1.2  (0.5–3.1) 1.1  (0.4–3.0) 1.1  (0.4–2.8)
  31–50 1.2  (0.5–2.8) 1.1  (0.4–2.8) 1.0  (0.4–2.7) 1.2  (0.5–3.0)
  51–100 1.4  (0.7–2.9) 1.7  (0.9–3.3) 1.6  (0.8–3.1) 1.5  (0.8–3.0)
 100– 1.0 1.0 1.0 1.0 
4 1–15 0.7  (0.4–1.4)   0.7  (0.4–1.4)
 16–30 0.6  (0.3–1.4)   0.6  (0.3–1.5)
 31–50 0.7  (0.4–1.5)   0.6  (0.3–1.3)
 51–100 0.8  (0.4–1.4)   0.8  (0.5–1.5)
 100– 1.0   1.0 
6 1–15 0.9  (0.5–1.9)  0.8  (0.4–1.7) 
 16–30 0.7  (0.3–1.6)  0.7  (0.3–1.5)  
 31–50 0.5  (0.2–1.2)  0.3  (0.1–0.9) 
 51–100 0.7  (0.4–1.4)  0.8  (0.4–1.5)  
 100– 1.0  1.0 
7 1–15 2.0  (0.8–5.4) 2.5  (1.0–6.7) 2.7  (1.1–6.5) 1.9  (0.7–5.2)
  16–30 1.3  (0.4–3.8) 1.2  (0.3–4.1) 1.2  (0.3–4.3) 1.2  (0.4–3.5)
  31–50 1.4  (0.5–3.8) 1.1  (0.3–4.0) 0.7  (0.2–3.2) 1.6  (0.6–4.2)
  51–100 1.1  (0.4–2.7) 1.9  (0.9–4.1) 2.0  (0.9–4.4) 1.0  (0.4–2.4)
  100– 1.0 1.0 1.0 1.0
9 1–15 1.7  (0.7–4.0)   1.7  (0.7–4.0
 16–30 1.5  (0.6–3.8)   1.5  (0.6–3.8)
 31–50 1.2  (0.5–3.1)   1.2  (0.5–3.1)
 51–100 0.7  (0.2–1.9)   0.7  (0.2–1.9)
  100– 1.0   1.0 
10 1–15 0.5  (0.2–1.5)   0.5  (0.2–1.5)
  16–30 0.9  (0.3–2.4)   0.9  (0.3–2.4)
  31–50 0.7  (0.3–2.1)   0.7  (0.3–2.1)
  51–100 0.9  (0.3–2.1)   0.9  (0.3–2.1)
  100– 1.0   1.0
   
a
 Due to small number of observations in all numbering groups, the pairs 3, 5, and 8 have been 
excluded from the pairwise analysis.
A Pair
B Order no. of the operation   
C Order numbering, minimum, HR (95% CI)   
D Order numbering, maximum, HR (95% CI)   
E Order numbering, stem, HR (95% CI)
F Order numbering, cup, HR (95% CI) 
new endoprosthesis models. Finally, 
the manufacturers of endoprostheses 
ought to take the learning effect into 
account when designing new devices. 
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